Goldman Sachs Group Inc Rx Sight, Inc. Transaction History
Goldman Sachs Group Inc
- $780 Billion
- Q3 2025
A detailed history of Goldman Sachs Group Inc transactions in Rx Sight, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 373,547 shares of RXST stock, worth $3.63 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
373,547
Previous 252,247
48.09%
Holding current value
$3.63 Million
Previous $3.28 Million
2.41%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding RXST
# of Institutions
168Shares Held
32.2MCall Options Held
64.6KPut Options Held
62.9K-
Black Rock Inc. New York, NY2.4MShares$23.4 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.19MShares$21.3 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.15MShares$20.9 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.83MShares$17.8 Million0.01% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI1.75MShares$17.1 Million0.02% of portfolio
About RxSight, Inc.
- Ticker RXST
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 27,638,900
- Market Cap $269M
- Description
- RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...